University of Edinburgh

Illumina launches Illumina SeqLab

Friday, July 17, 2015

Illumina, a San Diego-based provider of sequencing and array-based technologies, has launched Illumina SeqLab, an integrated solution for customers with HiSeq X Systems to enable large-scale human whole-genome sequencing operations. Designed to increase laboratory efficiency for population-scale, human whole-genome sequencing (HWGS), this new offering provides a complete solution for Illumina customers who need streamlined workflows with integrated sample tracking and fast and accurate analysis solutions.

[Read More]

International Progressive MS Alliance awards $28.4M in research grants

Tuesday, September 16, 2014

The International Progressive MS Alliance has awarded its first round of 22 research grants to investigators in nine countries, with the goal of removing barriers to developing treatments for progressive multiple sclerosis (MS). The alliance is a worldwide collaborative focused on finding solutions to progressive forms of multiple sclerosis that have so far eluded the scientific community.

[Read More]

Medical Research Council launches U.K. Dementias Research Platform

Thursday, June 19, 2014

The Medical Research Council (MRC) has launched the U.K. Dementias Research Platform (UKDP), a $27.2 million public-private partnership set up to speed up research into dementias. The collaboration aims to enable earlier detection, improved treatment and, ultimately, prevention of the disease by looking not just at what is going wrong in the brain, but at the brain in the context of the whole body.

[Read More]

Faculty of 1000 launches database of clinical trials articles

Wednesday, August 7, 2013

Faculty of 1000, the publisher of a range of services for life scientists and clinicians, has launched F1000Trials, a database designed to enable rapid discovery and understanding of articles about clinical trials. The database is a continually updated, comprehensive database of articles on randomized controlled trials and systematic reviews, drawn from more than 300 general and specialist medical journals.

[Read More]